| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Christopher T. Giordano
Also a director
President and Chief Executive Officer and Director
|
52 | Not stated | 2021 | $8,079,633 | |
|
Thomas A. McGauley
Interim Chief Financial Officer
|
53 |
Since 2024
2 years
|
2024 | $475,498 | |
|
Thomas R Staab Ii
Chief Financial Officer
Title from the Form 4 dated Sep 11, 2026
|
Not stated | Not stated | Not stated | Not reported | |
|
Stuart Rich
Also a director
Chief Medical Officer and Director
|
76 | Not stated | Not stated | $3,732,967 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Purchased shares, pre-funded warrants and warrants in the August 2024 Offering private placement
Purchased shares, pre-funded warrants and warrants in the August 2024 Offering private placement
Loading...
